Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit us at www.monoferric.com to learn more.
Karina Utkina, PharmD Medical Director, Medical Affairs Pharmacosmos Therapeutics Inc. 120 Headquarters Plaza East Tower, 6th Floor. Morristown, NJ 07960 M: +1 973-943-6171 F: +1 973-695-1927 E: [email protected]
|